Skip to main content

Table 2 Characteristics of the 32 discovery cohort patients evaluated with musculoskeletal ultrasonography

From: Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts

 

Anti-CCP-positive

(n = 16)

Anti-CCP-negative

(n = 16)

P value

Age, years, median

58

58

N.S.

Disease duration, years, median

10.5

10.5

N.S.

Female, number

14

13

N.S.

Fulfilled ACR-82 criteria number, median

4

4

N.S.

Meeting arthritis criterion according to ACR-82, number

13

14

N.S.

Meeting nephritis criterion according to ACR-82, number

4

2

N.S.

Conventional radiographs available (hands/wrists/feet)

16

16

N.S.

Erosions on radiography, number of individuals

4

0

N.S.

HAQ score, median

0.5

0.19

N.S.

Ever smoker, number of individuals

9

3

N.S.

Rheumatoid factor positive, number of individuals

6

1

N.S.

anti-CarP antibody level, median

275

102

0.04

anti-CarP positive, number of individuals

6

1

N.S.

Daily dosage of prednisolone, median

2.5

2.5

N.S.

  1. ACR American College of Rheumatology, HAQ health assessment questionnaire, anti-CarP antibodies targeting carbamylated proteins, N.S. not significant